Beam Therapeutics Inc. Finance Lease, Liability, Noncurrent
Beam Therapeutics Inc. (BEAM) had Finance Lease, Liability, Noncurrent of $304.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Balance Sheet › Liabilities
us-gaap:FinanceLeaseLiabilityNoncurrent · last filed 2023-11-08
- 2023-09-30: Finance Lease, Liability, Noncurrent $304.00K.
- 2023-06-30: Finance Lease, Liability, Noncurrent $875.00K.
- 2023-03-31: Finance Lease, Liability, Noncurrent $983.00K.
- 2022-12-31: Finance Lease, Liability, Noncurrent $1.15M.
| Period end | Finance Lease, Liability, Noncurrent |
|---|---|
| 2023-09-30 | $304.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $875.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $983.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.15M 10-Q · filed 2023-11-08 |
| 2022-09-30 | $1.39M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $1.79M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.40M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $3.01M 10-K · filed 2023-02-28 |
| 2021-09-30 | $3.60M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $4.18M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $4.74M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $5.29M 10-K · filed 2022-02-28 |
| 2020-09-30 | $4.45M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $4.90M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $5.33M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $4.41M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |